First live targeting of tumors with RNA-based technology

(Duke University Medical Center) Researchers at Duke University Medical Center have devised a way they might deliver the right therapy directly to tumors using special molecules, called aptamers, which specifically bind to living tumor tissue. They screened a large pool of aptamers in a rodent with liver cancer until they found the best molecule to bind to a tumor protein.

source : www.eurekalert.org

Related News:

• EXPOSED: "Scandalous Abuse" of the Elderly Being Killed With Psychiatric Medications
• Big Pharma executive murders 8-year-old son with Xanax and Ambien (opinion)
• CREON(R) (pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption In Children With Cystic Fibrosis
• Older Women with Gout at Risk of MI (CME/CE)
• Designing Easy-To-Use Products With The Help Of Arthritis Simulation Gloves
• Safer Hip, Knee And Dental Implants With Smart Coating
• Sutures Cause Fewer Complications Than Staples With Cesarean Deliveries
• Heal yourself in 15 days with the Health Ranger’s living juice recipe (part five)
• SMFM: Gene Variants Linked to Preterm Labor (CME/CE, with video)
• Brain Dopamine Receptor Density Correlates With Social Status

Details :
Submited at Monday, November 30th, 2009 at 1:00 pm on Cancer and Oncology by madison
Comment RSS 2.0 - leave a comment - trackback